Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BYFrontiers in medicine

Cumulative weight reduction across repeated acupoint catgut embedding sessions in obese women: a retrospective cohort study

  1. 1Department of Traditional Chinese Medicine, Peking University Third Hospital , ,

Abstract

Introduction: Acupoint catgut embedding (ACE), a minimally invasive acupuncture-derived technique, is gaining popularity in weight management, yet high-quality evidence focusing specifically on obese individuals remains sparse. This retrospective cohort study was designed to assess whether ACE is associated with lower body mass index (BMI) in obese women and whether this association accumulates across repeated sessions.

Methods: We included obese women (BMI ≥ 28 kg/m2, aged 18–60 years) who completed four ACE treatments and attended five study visits (baseline and four post-treatment assessments) at Peking University Third Hospital from January 2016 to September 2025. An untreated control group of volunteers with similar baseline age and BMI was enrolled prospectively; their weight was recorded at five biweekly visits without any intervention. Baseline variables and serial BMI measurements were compared between groups using non-parametric tests.

Results: Ninety-eight participants in the ACE group and 33 participants in the control group were analysed. The two groups were similar at baseline in age, height, weight, BMI, and waist circumference. By the third, fourth, and fifth visits, the ACE group showed significantly lower BMI than the control group (P = 0.043, 0.001, and <0.001, respectively). Within the ACE group, BMI at visits 2 through 5 was significantly lower than baseline, suggesting a cumulative association across successive sessions.

Conclusion: Some evidence from this study suggests that ACE may be associated with weight loss in obese women, with differences becoming detectable after two sessions and appearing to strengthen with additional treatments. No major adverse events were identified during the observed treatment period, supporting ACE as a possible adjunctive option for obesity care.

Related

  1. Acupoint Catgut Embedding Mitigates Sneezing Behavior in Allergic Rhinitis Rats and is Associated with the Attenuation of NMB-NMBR-cVRG Signaling.
    Mi Tang, Feng Xiang, Qinxiu Zhang
    Journal of inflammation researchPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  2. Clinical Outcomes of High-Flow Nasal Cannula Combined with Standardized Acupoint Application in Acute Exacerbations of COPD: A Retrospective Study.
    Binbin Li, Yamin Lu, Lei Pan +5
    International journal of chronic obstructive pulmonary diseasePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Cumulative obesity exposure and hepato-pancreato-biliary cancer risk following different weight-loss interventions: retrospective cohort study
    Ivan Kukeev, Yuval Arnon, Elchanan Quint +3
    Annals of medicine and surgery (2012)Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Respiratory pathogen epidemiology in children under 5 years hospitalized with acute respiratory infections in Qingdao, China: a retrospective, single-center, repeated cross-sectional surveillance study
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Handwriting-based Alzheimer’s disease classification on the DARWIN dataset: Repeated nested validation, task-level reduction, and cross-validated explainability
    Tehreem Fatima, Tahira Anwar Lashari, Momina Moetesum +1
    PLOS OnePeer-reviewedCC BY 4.0Full textNeuroscienceStatisticsPLOS
BibTeX
@article{ji2026cumulative,
  title = {{Cumulative weight reduction across repeated acupoint catgut embedding sessions in obese women: a retrospective cohort study}},
  author = {Xiaolan Ji and Xiyan Xin and Dong Li and Lili Hou and Yang Ye},
  journal = {Frontiers in medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fmed.2026.1945172},
  url = {https://europepmc.org/article/PMC/PMC13719440},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Cumulative weight reduction across repeated acupoint catgut embedding sessions in obese women: a retrospective cohort study
AU  - Xiaolan Ji
AU  - Xiyan Xin
AU  - Dong Li
AU  - Lili Hou
AU  - Yang Ye
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2026.1945172
UR  - https://europepmc.org/article/PMC/PMC13719440
AB  - Introduction: Acupoint catgut embedding (ACE), a minimally invasive acupuncture-derived technique, is gaining popularity in weight management, yet high-quality evidence focusing specifically on obese individuals remains sparse. This retrospective cohort study was designed to assess whether ACE is associated with lower body mass index (BMI) in obese women and whether this association accumulates across repeated sessions.  Methods: We included obese women (BMI ≥ 28 kg/m2, aged 18–60 years) who completed four ACE treatments and attended five study visits (baseline and four post-treatment assessments) at Peking University Third Hospital from January 2016 to September 2025. An untreated control group of volunteers with similar baseline age and BMI was enrolled prospectively; their weight was recorded at five biweekly visits without any intervention. Baseline variables and serial BMI measurements were compared between groups using non-parametric tests.  Results: Ninety-eight participants in the ACE group and 33 participants in the control group were analysed. The two groups were similar at baseline in age, height, weight, BMI, and waist circumference. By the third, fourth, and fifth visits, the ACE group showed significantly lower BMI than the control group (P = 0.043, 0.001, and <0.001, respectively). Within the ACE group, BMI at visits 2 through 5 was significantly lower than baseline, suggesting a cumulative association across successive sessions.  Conclusion: Some evidence from this study suggests that ACE may be associated with weight loss in obese women, with differences becoming detectable after two sessions and appearing to strengthen with additional treatments. No major adverse events were identified during the observed treatment period, supporting ACE as a possible adjunctive option for obesity care.
SN  - 2296-858X
ER  -